Cassia auriculata Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Caesalpiniaceae. |
| Habitat | Wild in dry regions of Madhya Pradesh, Tamil Nadu and Rajasthan. Cultivated in other parts of India. |
| English | Tanner’s Cassia. |
| Ayurvedic | Aaavartaki, Aaadaari. |
| Unani | Tarwar. |
| Siddha / Tamil | Aavaarai. |
| Folk | Tarwar. |
| Action | Roots—used in skin diseases and asthma. Flowers enter into compounds for diabetes, urinary disorders and nocturnal emissions. |
| Dosage | Whole plant—50–100 ml (CCRAS.) |
| Taxonomic Cohort | Genus Cassia (10 documented species); Family Caesalpiniaceae (25 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Cassia auriculata (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Caesalpiniaceae (primary family classification: Caesalpiniaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: Wild in dry regions of Madhya Pradesh, Tamil Nadu and Rajasthan. Cultivated in other parts of India.
Across classical and vernacular Indian systems of medicine, Cassia auriculata is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Tanner’s Cassia; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Aaavartaki, Aaadaari; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Tarwar; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Aavaarai; in regional Indian folk and vernacular ethnobotany as Tarwar. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Cassia auriculata are: Roots—used in skin diseases and asthma. Flowers enter into compounds for diabetes, urinary disorders and nocturnal emissions. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Cassia auriculata establish the following evidence base: Pod husk contains nonacosane and nonacosan-6-one, chrysophanol, emodin and rubiadin.

Botanical Reference 1: Senna auriculata — Botanical specimen

Botanical Reference 2: Senna auriculata — Botanical specimen

Botanical Reference 3: Cassia auriculata — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Cassia comprises 10 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Cassia absus (Action: Seed—bitter, blood-purifier, astringent, stimulant, diuretic. Used topically for…); Cassia alata (Action: Leaf—used in skin diseases like herpes, blotch, eczema, mycosis (washerman’s…); Cassia angustifolia (Action: Purgative (free from astringent action of rhubark type herbs, but causes gripe)…); Cassia fistula (Action: Flowers and pods— purgative, febrifugal, astringent, antibilious. Seed…); Cassia obovata (Action: An adulterant of the true senna. Leaves and seeds—purgative and anthelmintic) along with 4 additional congeneric species. Comparing Cassia auriculata alongside its congeners in genus Cassia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Caesalpiniaceae encompasses 25 documented medicinal species (1.38% of the 1,814-species flora). Other representative medicinal members of Caesalpiniaceae include: Bauhinia acuminata (Kaanchnaara), Bauhinia malabarica (Ashmantaka var), Bauhinia purpurea (Kovidaara), Bauhinia racemosa (Ashmantaka), Caesalpinia bonduc (Puutikaranja). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 25 medicinal species of family Caesalpiniaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Cassia auriculata are prescribed as follows: Whole plant—50–100 ml (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Cassia auriculata integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.